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The existence of the cerebrospinal fluid (CSF)
has been known since ancient times, but it was Cotugno who first described it in some detail in 1764. 1
Quoting from his treatise, "In these experiments
which I made on the bodies of nearly twenty adults,
and which I repeated at different times, I cou ld draw
off freely from the hollow of the spine, four, or even
sometimes five ounces of water : I commonly found it
very clear in such su bjects , though it sometimes inclined a little to a yellow color: but in fetus' strangled
in difficult labor, little as it was , I observed it to be
always red and opaque." 2 He also felt th at the CSF
was secreted by the arterial system, circulated in the
subarachnoid space and was reabsorbed by the
venous system .2 Matters remained in that state until
1891 when Quincke described a refinement in lumbar
puncture using a needle with a pointed stilette in it. 3
The first extensive treatise on CSF composition was
written by Mestrezat in 1912. 1 Since then there has
been very slow progress in the evaluation and interpretation of CSF even though there have been tremendous strides in the evaluation of other body
fluids, particularly blood .
One of the reasons for this is a fear of lumbar
puncture, a fear which is usually unwarranted . Unfortunately, this attitude permeates the medical profession almost as much as it does the lay public.
Tests such as cell counts, glucose, protein, and
semiquantitative tests for globulins such as the colloidal gold test were products of the first part of this
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century. As new developments occurred in blood
analysis these were applied to the CSF . These studies
did not lead to any advances in the clinical chemistry
of CSF, though they certainly had their place in
furthering our understanding of brain chemis try and
function .
The biggest advance in clinical CSF chemistry in
the past decade has been the emergence of an abbreviated CSF immunology. This followed the development and refinem en t of agar electrophoresis and imm unoprecipitation techniques.
The scope of this paper will include discussion of
these advances and some promising studies of CSF
enzymes in differential diagnosis as well as comment
on a recurrent problem , that of the interpretation of
bloody or xanthochromic CSF.
Blood in the CSF. Probably one of the most
frequently encountered problems is the bloody CSF.
Is it a subarachnoid hemorrhage or is it a traumatic
tap?
One of the best tests and the one most commonly
used is to do a cell count in the first tube and another
in a subsequent tube, usually the third . This should
be done even if the fluid looks grossly clear since
about 500 cells must be present before the fluid becomes hazy .4 •5 A significant change in the red blood
cell (RBC) count of the fluid indicates a traumatic tap
since the blood from a subarachnoid hemorrhage
should be homogeneous by the time it reaches the
lumbar sac. I say a "change" in the RBC , not just a
decrease, since a marked increase would also indicate
a tra umatic tap . One should also closely observe the
fluid as it comes out of the needle . Gross blood can
sometimes be seen streaming in the fluid. One may
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also see nonhomogeneous m1xmg in the fluid as it
drops into the tube. In addition, a very bloody traumatic tap (greater than 200,000 RBC / mm 3 ) will clot
on standing; this will not occur with subarachnoid
bleeding. Microscopic examination of the red cells is
of little value since crenation may occur with both
subarachnoid bleeding and a traumatic tap.
The next step if the fluid is bloody or colored
should be to centrifuge the fluid and determine the
color of the supernatant. One often hears the remark
that the fluid was xanthochromic, yet the fluid was
not centrifuged. Xanthochromia should refer to a
yellow color of the supernatant and should never be
used in reference to unspun CSF. This coloration is
usually due to either oxyhemoglobin, methernoglobin,
or bilirubin. Very rarely it may be due to other pigments such as carotene. 6
The sequence of events appears to be: hemoglobin is released from the red cells in the subarachnoid
space. This appears as oxyhemoglobin which in low
concentrations has an orange-red appearance. Depending on the amount of bleeding, one begins to see
a change in the coloration of the fluid to yellow
within a few hours to a day. This is due to the heme
being metabolized to bilirubin . In the case of a subdural or an intercerebral hematoma the fluid may
take on a brownish-yellow appearance due to the
presence of methernoglobin.
The supernatant fluid in a traumatic tap can give
one of two results. It is usually clear and colorless
since the red cells have not had time to break down . If
the RBC count is high, however, (> 12,000/ mrn 3 ),
some of the hemoglobin lea king out may be visible
irnmediately.5
True subarachnoid bleeding will give different
results depending on the time elapsed following the
bleed . One should keep in mind that it may take a
half hour for blood to reach the lumbar sac from the
cortex. The CSF may be indistinguishable from a
traumatic tap very shortly after the hemorrhage. In
his classic text on subarachnoid hemorrhage, Walton
observed xanthochrornia in 7% of patients within 2 to
4 hours, but by 4 to 6 hours, 64% had it, and by 12 to
24 hours, 100% had it. 7
There have been periodic attempts at using spectrophotometry as an aid in evaluating CSF pigments.
The three major pigments h ave rather characteristic
absorption patterns. Kronholm and Lintrup did a
study on 1,250 CSF samples and were able to develop
a set of formulae for determining the concentrations
of hemoglobin, methemoglobin, and bilirubin. Their

results showed that they could distinguish between
intercerebral hem atomas, subdural hematomas, and
subarachnoid hem orrhage (Table 1; Fig 1). 8
More recently, Kjellin and his group have expanded on this theme of CSF spectroscopy.9 • 10 Besides the disorders noted above, they have been a ble
to correlate various CSF patterns with hemorrhagic
infarctions, nonhernorrhagic infarctions, and ernboli,
as well as hem a tom as and subarachnoid hemorrhage.
In the past they have had to rely on clinical and
occasional autopsy conformation. When this was
available there was good correlation (Table 2 ).
I do not advocate th at these procedures be used
in place of others for evaluation of bloody CSF, but
as adjuncts which may be invaluable in deciding if a
!urn bar puncture was traumatic or not.
CSF Proteins and Immunoglobulins. There is considerable evidence that under norm al circumstances
the proteins of the CSF are derived from the serum . 11
The most notable exception is the so-called (tau)
protein seen in electrophoresis which is probably serum transferrin which has lost two sialic acid residues
(Fig 2). Normally, the CSF proteins are made up of
albumin, (3 globulin and 'Y globulin in the fr actions
0.58, 0.20, and 0.10 respectively. These get into the
CSF by secretion from brain tissue as well as from the
choroid plexus. Efflux of protein is presumably
through bulk flow , through the arachnoid granules.
Increases in protein , especially a lbumin , can come
from: 1) hemorrhage into the CSF, 2) breakdown in
the blood-brain barrier, 3) elevated serum protein , 4)
lesions of the choroid plexus or 5) blockage of CSF
flow, for example, spina l block , and 6) an efflux of
soluble proteins into the CSF with damage to brain
tissue.
CSF 'Y globulin or IgG also comes from the
serum in normal persons. In conditions where there is
Table I
CSF Pigments in Xanthochromic CSF
lnte rcerebral hematoma

Bilirubin > Hemoglobin
Methemoglobin > 25% total Hb

Subdural

Same as above, but metheme
may be very high

Subarachnoid

Hemoglobin > Bilirub in
Meth e mog lo bin < 25%

Traumatic

Same as subarachnoid though
Bilirubin should be neglig ible
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A

NORMAL

B BLOODY TAP BUT XANTHOCHROMIA PRESENT
CHb = .008)AM/L
CB= 0. l~M/L
C XANTHOCHROMIA
CHb = .32!4 MIL
D HEMOLYSIS
CHb = 3.2o/'M/L
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Fig I-Absorption pattern of CSF. A is from a patient who did not have active CNS disease. Bis from a patient who presented with a
history of confusion and a bloody CSF. The absence of a hemoglobin peak indicates blood was from a traumatic tap, but bilirubin indicates
an older subarachnoid hemorrhage. C is from a patient three weeks after an intercerebral hemorrhage. The hemoglobin peak is over 50%
metheme. D is hemolyzed blood.
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Table 2
Spectrophotometric Evaluation of CSF in Vascular Disease
Pattern (% of cases)*
Hemorrhagic in farct ion
or
Hema toma

Infarction

Verified Disease

24
46
8

71
9

Infarction
Cerebra l Hemorrhage
A neurysm
Trauma (not subdural)

Mixed

Hemorrhage

8
8
18

83

27

82

* A small number could not be interpreted, so figures do not a dd u p to !00%.

an increased serum 'Y globulin or IgG , this will be
reflected in the globulin composition of the CSF. In
addition, if there is a breakdown in the blood-brain
barrier, o ne may see an increase in the 'Y or lgG
fraction si mpl y because it makes up a higher proportion of the total protein in serum tha n it does in CSF.
There are times, though, when it appears that the
increased immune globulins are coming from the
brain itself. This was shown some yea rs ago by Frick
a nd Scheid-Seydel who used tagged lgG. 11 In multiple sclerosis (MS) patients they showed that a la rge
portion of the lgG was coming from somewhere
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Fig 2-Agar gel electrophoresis of concentrated CSF and unco ncentrated seru m . Note presence of a prealbumin a nd a ta u b and in
C SF which is not present in serum. Also note very broad ga mm a
band.

other than serum . At present it is thought that it is
coming from immune com petent cells sit uated in the
periphery of MS plaques. 12 Other conditions which
a re felt to reflect central nervous system (CNS) lgG
production with a ra ised CSF IgG are neurosyphilis
and s ubacute sclerosi ng panencephalitis. Disorders
such as meningitis or encepha litis may show increa sed IgG either from a brea kdown in the bloodbrain barrier or CNS production.
In 1964, Lowenthal applied agar electroph o resis
to CSF a nd was able to confirm this increase in immune globulins (See Fig 2; F ig 3). 13 Interestingly, conditions which have CNS immune globulin productio n
usually show discrete ba nding of the 'Y fraction while
those conditions in which the immune globulins originate in serum show a diffuse 'Y band . The next advance after agar electrophoresis was the develo pment
of immunoprecipitation methods, either electroimmunodiffusion or radia l immunodiffusio n
where antibody to the immune globulins is added to
the agar. The distance of the resultant precipitate
from the origin is proportional to the immune globulin concentration. The advantage over e lectrophoresis is that o nly a few microliters of CS F are
needed , and the subfractio ns of the immunoglobulins
can be measured . The disad vantage is that only one
protein fraction can be measured at a time.
Interestingly, the results by the different methods are remark a bly similar. 13 - 20 In MS some 75%
to 85% of the patients show a n a bnorm a l 'Y or IgG
level a t some time in their disease. Th ere is no rela tionship, however, to the stage o f the disease or to
the prognosis. Its value is therefore purely di agnostic .
Inflam mato ry diseases s uch as meningitis a nd encephalitis show an increased level in some 35% to
40%, the lowest level being in viral meningitis. Guillain-Barre syndrome shows an increase in 30% to
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F ig 3-Aga r gel elect rophoresis of CSF from two patients wi th
elevated gamma fraction. The first is a pat ient with acute lead
encepha lopathy. The diffuse gam ma band is ind icative of a serum
source whi le the multiple bands from the multiple sclerosis patient
indicate a CNS source.

50%. Agar electrophoresis shows that this is a serum
pattern . In other diseases such as degenerative disease, tumors, and vascular disease, the percentage
with increased 'Y or IgG levels is quite low, though in
these conditions the literature does vary a great deal
a nd probably reflects variations in the integrity of the
blood-brain barrier (Table 3 ).
CSF Enzymes. The meas urement of CSF enzyme
levels has no t yielded the kind of information which
was hoped for. The ones measured most common ly,
lactic dehydrogenase (LDH) and glu tamic-oxalacetic
Table 3
Conditions Giving Elevated CSF Gamma Globulin

Systemic Co nditi o ns with
Co nditions with I O Increase
Increased CSF Immune G lobulins in CSF Immune G Jobuli ns
Ci rrhosis with T y globulin
Myeloma
Diseases with breakdown BBB

Multiple Sclerosis
CNS Lues
SSPE

Vasculitis.----Vasculitis*
In fect i o n - - - - -1nfection *
Sarcoidosis-- -~Sa rcoidosis*
* In these three it is uncertain if the origin of the gamma
glob ulin is serum or CNS or both.
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Fig 4-CSF LDH isoenzymes measured by aga r gel electrophoresis. Normal LDH 2+ 3 = 0.40 and LDH I = 0.55. The
LDH 2+ 3 curve fo ll ows the tota l LDH pa ttern whi le the LDH I
actua lly showed a slight increase at two days when the absolute
amount was calculated.

transaminase (GOT), appear to be elevated whenever
there is significant disruption of brain tissues a nd do
not seem to be specific for a given disease. The LDH
is a lso increased when there is an increase in CSF
polymorp honuclear cells. This relation to tissue destruction is shown by the resu lts from a patient with
recurrent strokes. Using LDH isoenzymes, it is of
interest to no te the transient shift to the more anaerobic forms of LDH during the acute phase (Fig 4).
CSF LDH has been noted to be elevated in
meni ngitis of bacterial origin, but rarely in viral. 21 - 23
T his elevation has been used to try and d ifferentiate
partially treated bacterial from viral meningitis.2 4 For
technical reasons the results were not really conclusive, but it d id ind icate a differentiatio n could be
made by an elevated level in bacterial d isease.
More impressive was a study on CSF lactate
before, during, and a fter treatment. 25 Bacterial disease showed an elevated lactate level un til after full
treatment while aseptic meningitis was the same as
the controls. CSF pH showed the inverse pattern as
wou ld be expected .
While further studies wi ll be necessary to confirm these results, the outlook for a test to distinguish
partially treated bacterial disease from a viral meningitis looks promising.
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Table I is adapted from Kronholm and Lintrup, Acta Psychiat
Neural Scand (35:314-329, 1960).

13. LOWENTHAL A: Agar gel electrophoresis in neurology. Elsevier,
Amsterdam, 1964.

Table 2 is adapted from Kjellin and Soderstrom, J Neural Sci (23:
359-369, 1974 ).

14. SCHNECK SA, CLAMAN H: CSF immunoglobulins in multiple
sclerosis and other neurologic diseases. Measurement by electroimmunodiffusion. Arch Neurol 20:132-139, 1969.
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